AQUESTIVE THERAPEUTICS
5.0900
20-9月-24 15:59:59
15 分の遅延
株式
-0.1100
-2.12%
本日の幅
5.0550 - 5.2900
ISIN
N/A
ソース
NASDAQ
-
Aquestive Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
02 5 2023 16:31:30 提供 Nasdaq GlobeNewswire
-
Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences
26 4 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
20 4 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
18 4 2023 08:00:02 提供 Nasdaq GlobeNewswire
-
29 3 2023 08:30:00 提供 Nasdaq GlobeNewswire
-
07 3 2023 16:01:00 提供 Nasdaq GlobeNewswire
-
Aquestive Therapeutics to Participate in Oppenheimer 33rd Annual Healthcare Conference
01 3 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
22 2 2023 08:00:56 提供 Nasdaq GlobeNewswire
-
Aquestive Therapeutics Provides Business Update and Outlines Key 2023 Objectives
06 1 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
22 12 2022 08:00:00 提供 Nasdaq GlobeNewswire
-
29 11 2022 08:00:02 提供 Nasdaq GlobeNewswire
-
Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences
15 11 2022 08:00:02 提供 Nasdaq GlobeNewswire
-
Aquestive Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
01 11 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
Aquestive Therapeutics Licenses Sympazan® (clobazam) Oral Film to Assertio Holdings, Inc.
27 10 2022 09:05:24 提供 Nasdaq GlobeNewswire
-
24 10 2022 08:00:00 提供 Nasdaq GlobeNewswire
-
19 10 2022 08:00:02 提供 Nasdaq GlobeNewswire
-
11 10 2022 08:00:01 提供 Nasdaq GlobeNewswire